News

Eikon announces seven cancer-drug abstracts for ESMO

+1

Health

Eikon announces seven cancer-drug abstracts for ESMO

Marcus Bell · 2026-10-19T06:20:38.127Z

It's promising to see four oncology candidates advancing with updates for lung and prostate cancers at ESMO.

6 sourcesUpdated Oct 19, 20261 min read

+1

Eikon announces seven cancer-drug abstracts for ESMO — Photo: Pavel Danilyuk / Wikimedia Commons (Pexels)

Sponsored

Eikon Therapeutics announced that seven abstracts covering four clinical candidates will be presented at the 2026 European Society for Medical Oncology Congress in Madrid, beginning October 23. The updates include data on EIK1001 combined with pembrolizumab and chemotherapy for advanced non-small cell lung cancer; studies of the PARP1 inhibitor EIK1003 in advanced solid tumors and in combination with abiraterone for metastatic prostate cancer; and early results for CNS-penetrant PARP1 inhibitor EIK1004. The company also plans to report preliminary safety, tolerability and pharmacokinetic findings for its Werner helicase inhibitor EIK1005.

Sponsored

In this story:European Society for Medical OncologyEikon

Where do you stand?

European Society for Medical Oncology

Eikon

Sponsored

How it spread

Broke stocktitan.net · Oct 18, 6:05 PM ETLeft within the hour6 sources +3h on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments (2)

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Maya Lindstrom⚡7Oct 19, 2026
Early safety data matters most here before expecting too much from these advanced cancer treatments.
Marcus Bell⚡13Oct 19, 2026
It's promising to see four oncology candidates advancing with updates for lung and prostate cancers at ESMO.

Sponsored

More on this story

Back to News

Politics

Mike Johnson Declines House Minority Leader Bid After GOP Losses

After Republicans lost control of the House, Speaker Mike Johnson said he would not seek to lead the party in the minority, setting up a leadership contest that includes Steve Scalise and Jim Jordan. Johnson won reelection to his Louisiana seat and is expected to remain in the House as a rank-and-file member.

96 sources

Politics

Massie Files Eight Impeachment Articles Against Hegseth

John Oliver devoted a nearly 35-minute segment of Last Week Tonight to attacking Defense Secretary Pete Hegseth’s record, criticizing his leadership decisions, changes to civilian-protection safeguards and oversight of military operations. Oliver called for Congress to impeach and remove Hegseth, while highlighting the civilian deaths and controversies he says make Hegseth unfit for the role.

201 sources

Sponsored

Politics

Zemmour Confirms 2027 French Presidential Bid

Far-right Reconquête leader Eric Zemmour confirmed he will run in France’s 2027 presidential election, campaigning to preserve French national identity and proposing tougher immigration measures. He won 7% in 2022 and appears well behind Marine Le Pen and Jean-Luc Mélenchon in early polling.

6 sources